{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:56:19Z","timestamp":1759683379582},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s10571-014-0124-z","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T10:05:20Z","timestamp":1413367520000},"page":"293-301","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["mRNA Expression Levels of PGC-1\u03b1 in a Transgenic and a Toxin Model of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"35","author":[{"given":"Rita","family":"T\u00f6r\u00f6k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia Anna","family":"K\u00f3nya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9nes","family":"Z\u00e1dori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Veres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levente","family":"Szal\u00e1rdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Kliv\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"124_CR1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1515\/hsz-2013-0215","volume":"394","author":"S Aleshin","year":"2013","unstructured":"Aleshin S, Reiser G (2013) Role of the peroxisome proliferator-activated receptors (PPAR)-alpha, beta\/delta and gamma triad in regulation of reactive oxygen species signaling in brain. Biol Chem 394:1553\u20131570","journal-title":"Biol Chem"},{"key":"124_CR2","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"124_CR3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"E Brouillet","year":"2005","unstructured":"Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J Neurochem 95:1521\u20131540","journal-title":"J Neurochem"},{"key":"124_CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","volume":"29","author":"SE Browne","year":"2004","unstructured":"Browne SE, Beal MF (2004) The energetics of Huntington\u2019s disease. Neurochem Res 29:531\u2013546","journal-title":"Neurochem Res"},{"key":"124_CR5","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","volume":"18","author":"RK Chaturvedi","year":"2009","unstructured":"Chaturvedi RK, Adhihetty P, Shukla S, Hennessy T, Calingasan N, Yang L, Starkov A, Kiaei M, Cannella M, Sassone J, Ciammola A, Squitieri F, Beal MF (2009) Impaired PGC-1alpha function in muscle in Huntington\u2019s disease. Hum Mol Genet 18:3048\u20133065","journal-title":"Hum Mol Genet"},{"key":"124_CR6","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","volume":"19","author":"RK Chaturvedi","year":"2010","unstructured":"Chaturvedi RK, Calingasan NY, Yang L, Hennessey T, Johri A, Beal MF (2010) Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington\u2019s disease following chronic energy deprivation. Hum Mol Genet 19:3190\u20133205","journal-title":"Hum Mol Genet"},{"key":"124_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-1","volume":"6","author":"HV Che","year":"2011","unstructured":"Che HV, Metzger S, Portal E, Deyle C, Riess O, Nguyen HP (2011) Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease. Mol Neurodegener 6:1","journal-title":"Mol Neurodegener"},{"key":"124_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369","journal-title":"Cell"},{"key":"124_CR9","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1093\/hmg\/ddt242","volume":"22","author":"M Damiano","year":"2013","unstructured":"Damiano M, Diguet E, Malgorn C, D\u2019Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Deglon N, Beal MF, Brouillet E (2013) A role of mitochondrial complex II defects in genetic models of Huntington\u2019s disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet 22:3869\u20133882","journal-title":"Hum Mol Genet"},{"key":"124_CR10","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddt202","volume":"22","author":"J Eschbach","year":"2013","unstructured":"Eschbach J, Schwalenstocker B, Soyal SM, Bayer H, Wiesner D, Akimoto C, Nilsson AC, Birve A, Meyer T, Dupuis L, Danzer KM, Andersen PM, Witting A, Ludolph AC, Patsch W, Weydt P (2013) PGC-1alpha is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum Mol Genet 22:3477\u20133484","journal-title":"Hum Mol Genet"},{"key":"124_CR11","doi-asserted-by":"crossref","first-page":"42923","DOI":"10.1074\/jbc.M111.227496","volume":"286","author":"TK Felder","year":"2011","unstructured":"Felder TK, Soyal SM, Oberkofler H, Hahne P, Auer S, Weiss R, Gadermaier G, Miller K, Krempler F, Esterbauer H, Patsch W (2011) Characterization of novel peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) isoform in human liver. J Biol Chem 286:42923\u201342936","journal-title":"J Biol Chem"},{"key":"124_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","volume":"127","author":"BR Jarabek","year":"2004","unstructured":"Jarabek BR, Yasuda RP, Wolfe BB (2004) Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington\u2019s mouse model. Brain 127:505\u2013516","journal-title":"Brain"},{"key":"124_CR13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000327910","volume":"8","author":"A Johri","year":"2011","unstructured":"Johri A, Starkov AA, Chandra A, Hennessey T, Sharma A, Orobello S, Squitieri F, Yang L, Beal MF (2011) Truncated peroxisome proliferator-activated receptor-gamma coactivator 1alpha splice variant is severely altered in Huntington\u2019s disease. Neurodegener Dis 8:496\u2013503","journal-title":"Neurodegener Dis"},{"key":"124_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","volume":"62","author":"A Johri","year":"2013","unstructured":"Johri A, Chandra A, Beal MF (2013) PGC-1alpha, mitochondrial dysfunction, and Huntington\u2019s disease. Free Radic Biol Med 62:37\u201346","journal-title":"Free Radic Biol Med"},{"key":"124_CR15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/nbdi.2000.0327","volume":"8","author":"GW Kim","year":"2001","unstructured":"Kim GW, Chan PH (2001) Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mitochondrial toxin, 3-nitropropionic acid, in the mouse striatum. Neurobiol Dis 8:114\u2013126","journal-title":"Neurobiol Dis"},{"key":"124_CR16","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19:3919\u20133935","journal-title":"Hum Mol Genet"},{"key":"124_CR17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang H, Ward WF (2006) PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 30:145\u2013151","journal-title":"Adv Physiol Educ"},{"key":"124_CR18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795","journal-title":"Nature"},{"key":"124_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","volume":"1","author":"J Lin","year":"2005","unstructured":"Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361\u2013370","journal-title":"Cell Metab"},{"key":"124_CR20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/cdd.2009.22","volume":"16","author":"G Liot","year":"2009","unstructured":"Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 16:899\u2013909","journal-title":"Cell Death Differ"},{"key":"124_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"124_CR22","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/hmg\/ddr148","volume":"20","author":"E Martin","year":"2011","unstructured":"Martin E, Betuing S, Pages C, Cambon K, Auregan G, Deglon N, Roze E, Caboche J (2011) Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington\u2019s disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum Mol Genet 20:2422\u20132434","journal-title":"Hum Mol Genet"},{"key":"124_CR23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","volume":"127","author":"JK McGill","year":"2006","unstructured":"McGill JK, Beal MF (2006) PGC-1alpha, a new therapeutic target in Huntington\u2019s disease? Cell 127:465\u2013468","journal-title":"Cell"},{"key":"124_CR24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0168-0102(98)00010-8","volume":"30","author":"H Nishino","year":"1998","unstructured":"Nishino H, Nakajima K, Kumazaki M, Fukuda A, Muramatsu K, Deshpande SB, Inubushi T, Morikawa S, Borlongan CV, Sanberg PR (1998) Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neurosci Res 30:303\u2013312","journal-title":"Neurosci Res"},{"key":"124_CR25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","volume":"24","author":"P Puigserver","year":"2003","unstructured":"Puigserver P, Spiegelman BM (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24:78\u201390","journal-title":"Endocr Rev"},{"key":"124_CR26","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00439-012-1205-z","volume":"131","author":"EM Ramos","year":"2012","unstructured":"Ramos EM, Latourelle JC, Lee JH, Gillis T, Mysore JS, Squitieri F, Di Pardo A, Di Donato S, Hayden MR, Morrison PJ, Nance M, Ross CA, Margolis RL, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Marder K, Gusella JF, Lee JM, Alonso I, Sequeiros J, Myers RH, Macdonald ME (2012) Population stratification may bias analysis of PGC-1alpha as a modifier of age at Huntington disease motor onset. Hum Genet 131:1833\u20131840","journal-title":"Hum Genet"},{"key":"124_CR27","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/1389450111007011262","volume":"11","author":"K Rona-Voros","year":"2010","unstructured":"Rona-Voros K, Weydt P (2010) The role of PGC-1alpha in the pathogenesis of neurodegenerative disorders. Curr Drug Targets 11:1262\u20131269","journal-title":"Curr Drug Targets"},{"key":"124_CR28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","volume":"151","author":"JL Ruas","year":"2012","unstructured":"Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, Lanza IR, Rasbach KA, Okutsu M, Nair KS, Yan Z, Leinwand LA, Spiegelman BM (2012) A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151:1319\u20131331","journal-title":"Cell"},{"key":"124_CR29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1152\/physrev.00025.2007","volume":"88","author":"RC Scarpulla","year":"2008","unstructured":"Scarpulla RC (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88:611\u2013638","journal-title":"Physiol Rev"},{"key":"124_CR30","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/dds177","volume":"21","author":"SM Soyal","year":"2012","unstructured":"Soyal SM, Felder TK, Auer S, Hahne P, Oberkofler H, Witting A, Paulmichl M, Landwehrmeyer GB, Weydt P, Patsch W (2012) A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum Mol Genet 21:3461\u20133473","journal-title":"Hum Mol Genet"},{"key":"124_CR31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"J St-Pierre","year":"2006","unstructured":"St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397\u2013408","journal-title":"Cell"},{"key":"124_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000346267","volume":"12","author":"L Szalardy","year":"2013","unstructured":"Szalardy L, Zadori D, Plangar I, Vecsei L, Weydt P, Ludolph AC, Klivenyi P, Kovacs GG (2013) Neuropathology of partial PGC-1alpha deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases. Neurodegener Dis 12:177\u2013188","journal-title":"Neurodegener Dis"},{"key":"124_CR33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-4-10","volume":"4","author":"E Taherzadeh-Fard","year":"2009","unstructured":"Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L (2009) PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 4:10","journal-title":"Mol Neurodegener"},{"key":"124_CR34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuint.2005.11.011","volume":"48","author":"I Tunez","year":"2006","unstructured":"Tunez I, Collado JA, Medina FJ, Pena J, Del CMM, Jimena I, Franco F, Rueda I, Feijoo M, Muntane J, Montilla P (2006) 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington\u2019s disease in ovariectomized rats. Neurochem Int 48:367\u2013373","journal-title":"Neurochem Int"},{"key":"124_CR35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JP Vonsattel","year":"2011","unstructured":"Vonsattel JP, Keller C, Cortes Ramirez EP (2011) Huntington\u2019s disease\u2014neuropathology. Handb Clin Neurol 100:83\u2013100","journal-title":"Handb Clin Neurol"},{"key":"124_CR36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mito.2013.01.006","volume":"13","author":"T Wenz","year":"2013","unstructured":"Wenz T (2013) Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion 13:134\u2013142","journal-title":"Mitochondrion"},{"key":"124_CR37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ, Bammler TK, Strand AD, Cui L, Beyer RP, Easley CN, Smith AC, Krainc D, Luquet S, Sweet IR, Schwartz MW, La Spada AR (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4:349\u2013362","journal-title":"Cell Metab"},{"key":"124_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-4-3","volume":"4","author":"P Weydt","year":"2009","unstructured":"Weydt P, Soyal SM, Gellera C, Didonato S, Weidinger C, Oberkofler H, Landwehrmeyer GB, Patsch W (2009) The gene coding for PGC-1alpha modifies age at onset in Huntington\u2019s Disease. Mol Neurodegener 4:3","journal-title":"Mol Neurodegener"},{"key":"124_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-14-1","volume":"14","author":"P Weydt","year":"2014","unstructured":"Weydt P, Soyal SM, Landwehrmeyer GB, Patsch W (2014) A single nucleotide polymorphism in the coding region of PGC-1alpha is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurol 14:1","journal-title":"BMC Neurol"},{"key":"124_CR40","doi-asserted-by":"crossref","first-page":"32813","DOI":"10.1074\/jbc.M109.037556","volume":"284","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Huypens P, Adamson AW, Chang JS, Henagan TM, Boudreau A, Lenard NR, Burk D, Klein J, Perwitz N, Shin J, Fasshauer M, Kralli A, Gettys TW (2009) Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha. J Biol Chem 284:32813\u201332826","journal-title":"J Biol Chem"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-014-0124-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-014-0124-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-014-0124-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T06:19:33Z","timestamp":1565936373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-014-0124-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1007\/s10571-014-0124-z","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]}}}